Ajanta Pharma announces e-voting schedule for 47th AGM
Ajanta Pharma has announced the schedule for remote e-voting and its Forty-Seventh Annual General Meeting (AGM). The AGM will be held virtually on July 16, 2026. Remote e-voting is open from July 13 to July 15 for shareholders eligible as of July 9, 2026.

*this image is generated using AI for illustrative purposes only.
Ajanta Pharma has published the notice for e-voting and its Forty-Seventh Annual General Meeting (AGM) in the Mumbai editions of Free Press Journal and Navshakti on June 19, 2026. The meeting is scheduled to be held on July 16, 2026, at 11:00 a.m. IST via video conferencing. This disclosure complies with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 108 of the Companies Act, 2013.
The company has dispensed with the requirement of sending physical copies of the Notice and Annual Report for FY 2025-26. Instead, these documents were emailed to members on June 18, 2026, and are available on the company's website. The facility for remote e-voting will be available to members holding shares in physical or dematerialised form as on the cut-off date of July 9, 2026.
E-Voting and AGM Schedule
| Event | Date | Time |
|---|---|---|
| Remote E-Voting Commences | July 13, 2026 | 9:00 a.m. IST |
| Remote E-Voting Ends | July 15, 2026 | 5:00 p.m. IST |
| Annual General Meeting | July 16, 2026 | 11:00 a.m. IST |
| Cut-off Date (Voting Eligibility) | July 9, 2026 | - |
Shareholders who cast their vote via remote e-voting prior to the AGM may attend the meeting but are not entitled to vote again. Those who have not voted remotely can exercise their right through the e-voting system during the AGM. The venue of the meeting is deemed to be the Registered Office of the company in Mumbai.
Historical Stock Returns for Ajanta Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.04% | +5.31% | +13.04% | +28.79% | +27.99% | +138.34% |
What key resolutions are expected to be presented during the AGM that could influence Ajanta Pharma's strategic direction?
How might the shift to fully digital distribution of annual reports impact shareholder engagement and participation levels?
What are the anticipated market reactions to the outcomes of the e-voting, particularly regarding potential dividend declarations or board changes?































